Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Azs, Rohatiner"'
Autor:
HS Dhaliwal, AZS Rohatiner, W Gregory, MA Richards, PWM Johnson, JS Whelan, CJ Gallagher, J Matthews, TS Ganesan, MJ Barnett, JH Waxman, AG Stansfeld, PFM Wrigley, ML Slevin, JS Malpas, TA Lister
Publikováno v:
British Journal of Cancer
One hundred and eighteen consecutive adults with newly diagnosed intermediate and high-grade non-Hodgkin's lymphoma were treated with chemotherapy comprising Doxorubicin, Cyclophosphamide, Vincristine and Prednisolone with mid-cycle Methotrexate (MTX
Autor:
AM Oza, TS Ganesan, M Dorreen, PW Johnson, J Waxman, W Gregory, J Lim, J Wright, L Dadiotis, V Barbounis, AG Stansfeld, AZS Rohatiner, JS Malpas, PFM Wrigley, TA Lister
Publikováno v:
British Journal of Cancer
A total of 164 consecutive adults with newly confirmed stage IIIB, IVA or IVB Hodgkin's disease (HD) commenced cyclical combination chemotherapy comprising mustine, vinblastine, prednisolone and procarbazine (MVPP) every 6 weeks (145 patients) or min
High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemia
Autor:
AZS Rohatiner, R Bassan, R Battista, MJ Barnett, W Gregory, J Lim, J Amess, A Oza, T Barbui, M Horton, T Chisesi, TA Lister
Publikováno v:
British Journal of Cancer
In a study conducted at St Bartholomew's Hospital between 1972 and 1982, using moderately intensive therapy (OPAL/HEAV'D), a low blast count at presentation (less than 10 x 10(9) 1(-1)) and common ALL (C-ALL) phenotype correlated favourably with dura
Autor:
Shamash, J., Lee, S. M., Dp, Deakin, Jh, Scarffe, Gr, Morgenstern, Joan Chang, Gupta, R. K., Azs, Rohatiner, John Radford, Lister, T. A.
Publikováno v:
ResearcherID
University of Manchester-PURE
University of Manchester-PURE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::95842c09664efae9ba12a371745daff0
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000081955000065&KeyUID=WOS:000081955000065
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000081955000065&KeyUID=WOS:000081955000065
Autor:
John Radford, Azs, Rohatiner, Wdj, Ryder, Dp, Deakin, Barbui, T., Lucie, N., Rossi, A., Dj, Dunlop, Rd, James, Rk, Gupta, Ra, Cowan, Shamash, J., Joan Chang, Ta, Lister
Publikováno v:
University of Manchester-PURE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::14e986daaf6dbe2da4cf85966927fca5
https://www.researchtest.ppad.man.ac.uk/portal/en/publications/fourteen-years-clinical-trial-experience-with-the-chlvppeva-hybrid-regimen-as-first-line-treatment-for-advanced-hodgkins-disease-hd(3c680df0-0c80-411c-b41c-1d1867e50f63).html
https://www.researchtest.ppad.man.ac.uk/portal/en/publications/fourteen-years-clinical-trial-experience-with-the-chlvppeva-hybrid-regimen-as-first-line-treatment-for-advanced-hodgkins-disease-hd(3c680df0-0c80-411c-b41c-1d1867e50f63).html